147 related articles for article (PubMed ID: 11576759)
1. Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium.
Stewart RJ; Chen B; Dowlatshahi D; MacQueen GM; Young LT
Brain Res Bull; 2001 Jul; 55(5):625-9. PubMed ID: 11576759
[TBL] [Abstract][Full Text] [Related]
2. G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death.
Dowlatshahi D; MacQueen GM; Wang JF; Reiach JS; Young LT
J Neurochem; 1999 Sep; 73(3):1121-6. PubMed ID: 10461903
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction pathways. Molecular targets for lithium's actions.
Manji HK; Potter WZ; Lenox RH
Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
[TBL] [Abstract][Full Text] [Related]
4. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder.
Yamada S; Yamamoto M; Ozawa H; Riederer P; Saito T
J Neural Transm (Vienna); 2003 Jun; 110(6):671-80. PubMed ID: 12768362
[TBL] [Abstract][Full Text] [Related]
5. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder.
Young LT; Li PP; Kish SJ; Siu KP; Kamble A; Hornykiewicz O; Warsh JJ
J Neurochem; 1993 Sep; 61(3):890-8. PubMed ID: 8395565
[TBL] [Abstract][Full Text] [Related]
6. Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection.
Knable MB
Schizophr Res; 1999 Sep; 39(2):149-52; discussion 163. PubMed ID: 10507526
[TBL] [Abstract][Full Text] [Related]
7. Differentiation-induced alterations in cyclic AMP signaling in the Cath.a differentiated (CAD) neuronal cell line.
Johnston CA; Beazely MA; Bilodeau ML; Andrisani O; Watts VJ
J Neurochem; 2004 Mar; 88(6):1497-508. PubMed ID: 15009651
[TBL] [Abstract][Full Text] [Related]
8. Postreceptor pathways for signal transduction in depression and bipolar disorder.
Young LT
J Psychiatry Neurosci; 2001; 26 Suppl(Suppl):S17-22. PubMed ID: 11590965
[TBL] [Abstract][Full Text] [Related]
9. Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.
Gibbons AS; Jeon WJ; Scarr E; Dean B
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26475745
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells.
Wang JF; Asghari V; Rockel C; Young LT
Neuroscience; 1999; 91(2):771-6. PubMed ID: 10366032
[TBL] [Abstract][Full Text] [Related]
11. Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes.
Stoll AL; Severus WE
Harv Rev Psychiatry; 1996; 4(2):77-89. PubMed ID: 9384977
[TBL] [Abstract][Full Text] [Related]
12. Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder.
Meador-Woodruff JH; Hogg AJ; Smith RE
Brain Res Bull; 2001 Jul; 55(5):631-40. PubMed ID: 11576760
[TBL] [Abstract][Full Text] [Related]
13. [Neuropatological and neurochemical abnormalities in bipolar disorder].
Frey BN; Fonseca MM; Machado-Vieira R; Soares JC; Kapczinski F
Braz J Psychiatry; 2004 Sep; 26(3):180-8. PubMed ID: 15645064
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium.
Knable MB; Torrey EF; Webster MJ; Bartko JJ
Brain Res Bull; 2001 Jul; 55(5):651-9. PubMed ID: 11576762
[TBL] [Abstract][Full Text] [Related]
15. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
[TBL] [Abstract][Full Text] [Related]
16. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
17. Signaling networks in the pathophysiology and treatment of mood disorders.
Gould TD; Manji HK
J Psychosom Res; 2002 Aug; 53(2):687-97. PubMed ID: 12169343
[TBL] [Abstract][Full Text] [Related]
18. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.
Chen B; Dowlatshahi D; MacQueen GM; Wang JF; Young LT
Biol Psychiatry; 2001 Aug; 50(4):260-5. PubMed ID: 11522260
[TBL] [Abstract][Full Text] [Related]
19. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.
Chen G; Hasanat KA; Bebchuk JM; Moore GJ; Glitz D; Manji HK
Psychosom Med; 1999; 61(5):599-617. PubMed ID: 10511011
[TBL] [Abstract][Full Text] [Related]
20. The calcium second messenger system in bipolar disorders: data supporting new research directions.
Dubovsky SL; Murphy J; Christiano J; Lee C
J Neuropsychiatry Clin Neurosci; 1992; 4(1):3-14. PubMed ID: 1320969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
